Abacavir and lamivudine for the treatment of human immunodeficiency virus

Author： Rizzardini Giuliano   Zucchi Patrizia  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.12, Iss.13, 2011-09, pp. : 2129-2138

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evaluation of a Pharmacogenetic Test in Thailand for Abacavir Hypersensitivity Screening in Human Immunodeficiency Virus Infection

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 11, Iss. 3, 2013-09 ,pp. : 231-236

Bentham Science Publishers

Access to resources Recommend Favorite

Lopinavir/ritonavir in the treatment of human immunodeficiency virus infection

By Kaplan Susan S   Hicks Charles B  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 9, 2005-08 ,pp. : 1573-1585

Informa Healthcare

Access to resources Recommend Favorite

Abacavir/lamivudine fixed-dose combination tablet for the treatment of HIV-1 infection

By Taylor Clare L   Wilkins Edmund GL  

Future Virology, Vol. 2, Iss. 1, 2007-01 ,pp. : 11-21

Future Medicine

Access to resources Recommend Favorite

Abacavir and lamivudine combination

By Somboonwit Charurut   Kurtyka Don   Paula Velez Ana  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 5, Iss. 12, 2009-12 ,pp. : 1599-1606

Informa Healthcare

Access to resources Recommend Favorite

Pathogenesis and treatment of human immunodeficiency virus-associated cytomegalovirus retinitis

By Tan Suiyi   Liu Shuwen   Jiang Shibo  

Future Virology, Vol. 6, Iss. 4, 2011-04 ,pp. : 503-520

Future Medicine

Access to resources Recommend Favorite